Smith S D, Katz J, Quigley H A
Dana Center for Preventive Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, Maryland, USA.
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1419-28.
To detect and estimate the rate of progression of visual field loss in subjects with glaucoma who undergo long-term automated perimetric visual field testing.
Automated visual field data were obtained for subjects with glaucomatous visual field loss and a minimum of seven threshold field tests over at least 4.5 years. Univariate linear regression was performed with respect to mean deviation (MD), corrected pattern standard deviation (CPSD), mean thresholds of clusters corresponding to the Glaucoma Hemifield Test (GHT), and thresholds of 52 individual test locations. Subjects were classified as progressive or stable (unchanged or improved) based on the slope and statistical significance of these parameters. Adjusted P values were used to maintain the overall type 1 error at 5%.
One hundred ninety-one subjects with a mean follow-up period of 7.1 years (range, 4.5 to 10.5 years) and a mean number of visual field tests of 9.5 (range, 7 to 16) were included. Twenty-four subjects (12.6%) showed progression in MD (mean slope [95% confidence interval], -1.26 [-1.50, -1.01] dB/year), and 27 (14.1%) showed progression in CPSD (mean slope [95% confidence interval], 0.71 [0.58, 0.84] dB/year). Thirty-five subjects (18.3%) had > or = 1 progressive GHT cluster. The mean slope in progressive clusters ranged from -1.51 [-1.82, -1.20] to -2.84 [-3.39, -2.29] dB/year. Thirty-six subjects (18.8%) had > or = 1 progressive individual test locations. Fifty-two subjects (27.2%) were classified as progressive based on progression of CPSD, > or = 1 cluster and/or > or = 1 point.
Fewer than 1 in 3 subjects progressed by any one of the criteria for progression over an average of 7.1 years. Rates of progression that could be statistically confirmed were in the range of approximately 1 to 5 dB/year, depending on the number of fields, the variability over time, and the parameter assessed (global indices, GHT clusters, or individual points). No correlation between initial visual field status and the rate of progression was found. A minimum of approximately 5 years of follow-up with annual perimetry would be required to detect significant changes in the visual field by linear regression.
检测并评估接受长期自动视野检测的青光眼患者视野缺损的进展速率。
获取青光眼视野缺损患者的自动视野数据,这些患者在至少4.5年的时间里至少接受了7次阈值视野检测。对平均偏差(MD)、校正模式标准差(CPSD)、与青光眼半视野检测(GHT)相对应的簇的平均阈值以及52个单独检测位置的阈值进行单变量线性回归分析。根据这些参数的斜率和统计学意义,将患者分为进展型或稳定型(未改变或改善)。使用校正后的P值将总体I型错误维持在5%。
纳入了191名患者,平均随访期为7.1年(范围为4.5至10.5年),平均视野检测次数为9.5次(范围为7至16次)。24名患者(12.6%)的MD显示进展(平均斜率[95%置信区间],-1.26[-1.50,-1.01]dB/年),27名患者(14.1%)的CPSD显示进展(平均斜率[95%置信区间],0.71[0.58,0.84]dB/年)。35名患者(18.3%)有≥1个进展性GHT簇。进展性簇的平均斜率范围为-1.51[-1.82,-1.20]至-2.84[-3.39,-2.29]dB/年。36名患者(18.8%)有≥1个进展性单独检测位置。52名患者(27.2%)根据CPSD进展、≥1个簇和/或≥1个点被分类为进展型。
在平均7.1年的时间里,每3名患者中进展型患者少于1名。根据视野检测次数、随时间的变异性以及评估的参数(整体指标、GHT簇或单独点),统计学上可确认的进展速率在约1至5dB/年的范围内。未发现初始视野状态与进展速率之间存在相关性。通过线性回归检测视野的显著变化,每年进行视野检测至少需要约5年的随访时间。